THRL vs. AGR, PHP, IHR, LABS, MXF, DLN, IWG, GPOR, BYG, and LXI
Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Derwent London (DLN), IWG (IWG), Great Portland Estates (GPOR), Big Yellow Group (BYG), and Lxi Reit (LXI). These companies are all part of the "real estate" sector.
Target Healthcare REIT vs. Its Competitors
Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.
Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.
Assura currently has a consensus target price of GBX 51, suggesting a potential upside of 1.80%. Given Assura's stronger consensus rating and higher possible upside, equities research analysts plainly believe Assura is more favorable than Target Healthcare REIT.
In the previous week, Assura and Assura both had 1 articles in the media. Target Healthcare REIT's average media sentiment score of 1.11 beat Assura's score of 0.59 indicating that Target Healthcare REIT is being referred to more favorably in the news media.
Target Healthcare REIT has lower revenue, but higher earnings than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.
Assura has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500.
Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 6.0%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 6.0%. Assura pays out -286.8% of its earnings in the form of a dividend. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
73.7% of Assura shares are held by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are held by institutional investors. 8.4% of Assura shares are held by company insiders. Comparatively, 0.1% of Target Healthcare REIT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Target Healthcare REIT beats Assura on 9 of the 16 factors compared between the two stocks.
Get Target Healthcare REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Target Healthcare REIT Competitors List
Related Companies and Tools
This page (LON:THRL) was last updated on 7/10/2025 by MarketBeat.com Staff
